Platelets are responsible for the accumulation of β-amyloid in blood clots inside and around blood vessels in mouse brain after thrombosis (original) (raw)

Unaltered Plasma Levels of β-Amyloid(1–40) and β-Amyloid(1–42) upon Stimulation of Human Platelets

Annika Ohrfelt

Dementia and Geriatric Cognitive Disorders, 2003

View PDFchevron_right

Platelets provide human tissue to unravel pathogenic mechanisms of Alzheimer disease

Monica Diluca

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2004

View PDFchevron_right

Amyloid Precursor Protein and Amyloid β Peptide in Human Platelets

Anibh Das

Journal of Biological Chemistry, 2001

View PDFchevron_right

Platelet amyloid precursor protein processing: A bio-marker for Alzheimer's disease

Linda S Hynan

Journal of the Neurological Sciences, 2006

View PDFchevron_right

Alzheimer's Disease Platelets in Atherosclerosis: A New Role for ß-Amyloid Peptide Beyond

Alain Tedgui

View PDFchevron_right

Inhibition of platelet activation by the Alzheimer's disease amyloid precursor protein

Colin Masters

British Journal of Haematology, 1998

View PDFchevron_right

Microvascular damage and platelet abnormalities in early Alzheimer's disease

Barbara Borroni

Journal of the Neurological Sciences, 2002

View PDFchevron_right

Alzheimer disease and platelets: how’s that relevant

Giovanni Ricevuti

Immunity & Ageing, 2012

View PDFchevron_right

Plasma Fibrinogen Is a Natural Deterrent to Amyloid β–Induced Platelet Activation and Neuronal Toxicity

Abhishek Jauhari

View PDFchevron_right

Platelet Activation in Alzheimer Disease

Luciano Kolodny

Archives of Neurology, 1998

View PDFchevron_right

Plasma fibrinogen is a natural deterrent to amyloid beta-induced platelet activation and neuronal toxicity

Vijay Sonkar

Molecular medicine (Cambridge, Mass.), 2016

View PDFchevron_right

Platelets and Alzheimer’s disease: Potential of APP as a biomarker

Qiao-xin Li

World Journal of Psychiatry, 2012

View PDFchevron_right

Low-density platelet populations demonstrate low in vivo activity in sporadic Alzheimer disease

Petter Järemo, Staffan Nilsson

Platelets, 2012

View PDFchevron_right

Platelets as a peripheral district where to study pathogenetic mechanisms of Alzheimer disease: the case of amyloid precursor protein

Barbara Borroni

European Journal of Pharmacology, 2000

View PDFchevron_right

Intact Alzheimer amyloid precursor protein (APP) is present in platelet membranes and is encoded by platelet mRNA

Joseph Gardella

Biochemical and Biophysical Research Communications, 1990

View PDFchevron_right

Blood cell markers in Alzheimer Disease: Amyloid Precursor Protein form ratio in platelets

Monica Diluca

Experimental gerontology

View PDFchevron_right

β-Amyloid augments platelet aggregation: reduced activity of familial angiopathy-associated mutants

A. Bush

Molecular Psychiatry, 1998

View PDFchevron_right

Amyloid Precursor Protein in Platelets of Patients With Alzheimer Disease

Gian Carlo Lenzi

Archives of Neurology, 2001

View PDFchevron_right

Platelets, a reliable source for peripheral Alzheimer’s disease biomarkers?

Maria Zellner

Acta Neuropathologica Communications, 2014

View PDFchevron_right

Platelet APP Processing: Is It a Tool to Explore the Pathophysiology of Alzheimer’s Disease? A Systematic Review

Manuel Glauco Carbone

Life, 2021

View PDFchevron_right

Platelets in Alzheimer's Disease-Associated Cellular Senescence and Inflammation

Marta Balietti

Current Pharmaceutical Design, 2013

View PDFchevron_right

Platelet as a physiological model to investigate apoptotic mechanisms in Alzheimer β-amyloid peptide production

Marta Balietti, Tiziana Casoli, Patrizia Fattoretti

Mechanisms of Ageing and Development, 2008

View PDFchevron_right

Platelet amyloid precursor protein forms in AD: a peripheral diagnostic tool and a pharmacological target

Luigi Caimi

Mechanisms of Ageing and Development, 2001

View PDFchevron_right